Makan Cheraghpour

Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

Makan Cheraghpour, Hossein Imani, Shahrzad Ommi et al. · Phytotherapy Research · 2019 · 86 citations

The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial

Zahra Yari, Makan Cheraghpour, Seyed Moayed Alavian et al. · European Journal of Clinical Nutrition · 2020 · 69 citations

Nutrition, Hepatology, Health Sciences +9

New anthropometric indices or old ones: Which is the better predictor of body fat?

Elham Ehrampoush, Peyman Arasteh, Reza Homayounfar et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2016 · 58 citations

Obesity, Metabolic Syndrome, Nutrition +11

The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial

Mina Bahrami, Makan Cheraghpour, Sima Jafarirad et al. · Complementary Therapies in Medicine · 2020 · 57 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +9

<p>Association Metabolic Obesity Phenotypes with Cardiometabolic Index, Atherogenic Index of Plasma and Novel Anthropometric Indices: A Link of FTO-rs9939609 Polymorphism</p>

Farhad Abolnezhadian, Seyed Ahmad Hosseini, Meysam Alipour et al. · Vascular Health and Risk Management · 2020 · 50 citations · Full text